Abstract
FTO, the first RNA demethylase discovered, mediates the demethylation of internal N 6 -methyladenosine (m 6 A) and N 6 , 2-O-dimethyladenosine (m 6 A m ) at the +1 position from the 5′ cap in mRNA. Here we demonstrate that the cellular distribution of FTO is distinct among different cell lines, affecting the access of FTO to different RNA substrates. We find that FTO binds multiple RNA species, including mRNA, snRNA, and tRNA, and can demethylate internal m 6 A and cap m 6 A m in mRNA, internal m 6 A in U6 RNA, internal and cap m 6 A m in snRNAs, and N 1 -methyladenosine (m 1 A) in tRNA. FTO-mediated demethylation has a greater effect on the transcript levels of mRNAs possessing internal m 6 A than the ones with cap m 6 A m in the tested cells. We also show that FTO can directly repress translation by catalyzing m 1 A tRNA demethylation. Collectively, FTO-mediated RNA demethylation occurs to m 6 A and m 6 A m in mRNA and snRNA as well as m 1 A in tRNA. Wei et al. show that FTO mediates internal m 6 A and cap m 6 A m demethylation of polyadenylated RNA with differential substrate preferences in the nucleus versus the cytoplasm, in which the internal m 6 A demethylation correlates with transcript-level changes. FTO also affects snRNA m 6 A and m 6 A m levels and mediates tRNA m 1 A demethylation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 973-985.e5 |
| Journal | Molecular cell |
| Volume | 71 |
| Issue number | 6 |
| DOIs | |
| State | Published - Sep 20 2018 |
Funding
This work is supported by the U.S. National Insititutes of Health ( GM071440 and HG008935 to C.H., and CA214965 to J.C.) and the National Basic Research Program of China ( 2014CB964900 to G.J.). The Mass Spectrometry Facility of the University of Chicago is funded by the U.S. National Science Foundation ( CHE-1048528 ). The University of Chicago Cancer Center is supported by the U.S. National Institutes of Health CA014599 . C.H. is an investigator of the Howard Hughes Medical Institute. This work is supported by the U.S. National Insititutes of Health (GM071440 and HG008935 to C.H., and CA214965 to J.C.) and the National Basic Research Program of China (2014CB964900 to G.J.). The Mass Spectrometry Facility of the University of Chicago is funded by the U.S. National Science Foundation (CHE-1048528). The University of Chicago Cancer Center is supported by the U.S. National Institutes of Health CA014599. C.H. is an investigator of the Howard Hughes Medical Institute.
Keywords
- FTO
- cap m A
- cytoplasmic demethylation
- m A
- nuclear m A demethylation
- snRNA demethylation
- tRNA m A demethylation
- translation regulation
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology